RDY (Dr. Reddy's Laboratories Limited American Depositary Shares) Stock Analysis - Insider Trades

Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) is a publicly traded Healthcare sector company. As of May 21, 2026, RDY trades at $13.63 with a market cap of $11.32B and a P/E ratio of 0.00. RDY moved +1.23% today. Year to date, RDY is -1.37%; over the trailing twelve months it is -6.00%. Its 52-week range spans $12.19 to $16.19. Analyst consensus is sell with an average price target of $0.00. Rallies surfaces RDY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RDY stock inside the company?

Rallies tracks RDY insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

RDY Key Metrics

Key financial metrics for RDY
MetricValue
Price$13.63
Market Cap$11.32B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.11%
52-Week High$16.19
52-Week Low$12.19
Volume10
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest RDY News

RDY Analyst Consensus

1 analysts cover RDY: 0 strong buy, 0 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $0.00.

Common questions about RDY

Who is trading RDY stock inside the company?
Rallies tracks RDY insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for RDY?
Yes. Rallies tracks RDY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RDY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RDY. It does not provide personalized investment advice.
RDY

RDY